GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Interest Coverage

YSB (HKSE:09885) Interest Coverage : 0 (At Loss) (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is YSB Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. YSB's Operating Income for the six months ended in Dec. 2024 was HK$-55 Mil. YSB's Interest Expense for the six months ended in Dec. 2024 was HK$-6 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for YSB's Interest Coverage or its related term are showing as below:


HKSE:09885's Interest Coverage is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 8.17
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


YSB Interest Coverage Historical Data

The historical data trend for YSB's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

YSB Interest Coverage Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage
- - - - -

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Interest Coverage Get a 7-Day Free Trial - 2.31 - - -

Competitive Comparison of YSB's Interest Coverage

For the Pharmaceutical Retailers subindustry, YSB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YSB's Interest Coverage Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's Interest Coverage distribution charts can be found below:

* The bar in red indicates where YSB's Interest Coverage falls into.


;
;

YSB Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

YSB's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, YSB's Interest Expense was HK$-12 Mil. Its Operating Income was HK$-89 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$139 Mil.

YSB did not have earnings to cover the interest expense.

YSB's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the six months ended in Dec. 2024, YSB's Interest Expense was HK$-6 Mil. Its Operating Income was HK$-55 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$139 Mil.

YSB did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


YSB  (HKSE:09885) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


YSB Interest Coverage Related Terms

Thank you for viewing the detailed overview of YSB's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


YSB Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Group mainly engaged in i) wholesales of pharmaceutical and healthcare products offline or online through its online platform; ii) retail of pharmaceutical and healthcare products through its retail shops; iii) operating online platform that enable the pharmaceutical distributors and vendors to sell their own pharmaceutical and healthcare products using the Group's online platform; iv) providing SaaS solution to downstream pharmacies to streamline their inventory management; and v) providing medical testing services to primary healthcare institutions. The Group principally operates in the PRC and generates the majority of its revenues from the PRC.
Executives
Dcm Investment Management Ix, L.p. 2201 Interest of corporation controlled by you
Dcm Investments (de 5), Llc 2101 Beneficial owner
Dcm Ix International Ltd 2201 Interest of corporation controlled by you
Dcm Ix, L.p. 2201 Interest of corporation controlled by you
Zhang Buzhen 2501 Other
Chen Xiaohong 2201 Interest of corporation controlled by you
H Capital V Gp, L.p. 2201 Interest of corporation controlled by you
H Capital V Gp, Ltd. 2201 Interest of corporation controlled by you
H Capital V, L.p. 2101 Beneficial owner
Tmf (cayman) Ltd. 2301 Trustee
Miyt Worldwide Limited 2201 Interest of corporation controlled by you
Coleman Iii Charles 2201 Interest of corporation controlled by you
Internet Fund Holding V. Ltd. 2201 Interest of corporation controlled by you
Shleifer Scott 2201 Interest of corporation controlled by you
Tiger Global Management, Llc 2102 Investment manager

YSB Headlines

No Headlines